Aster DM Quality Care (ASTERDM) Q1 26/27 earnings summary

Executive summary

• The merger of Aster DM Healthcare and Quality Care, effective July 1, 2026, created a unified healthcare platform with 39 hospitals and over 10,800 beds, executed with strong cultural integration and zero operational friction.

• Strategic priorities include scaling super-specialty care, expanding into Tier 2 and Tier 3 cities, and driving patient-centric innovation through digital health and advanced clinical protocols.

• The integration is expected to unlock significant operational and clinical synergies, with a focus on long-term value creation and standardized best practices.

• Auditors expressed an unmodified review conclusion on unaudited consolidated and standalone financial results for the quarter ended June 30, 2026.

• Strategic rationale includes scale, enhanced metrics, synergies, diversification, growth potential, and backing by Blackstone.

Financial highlights

• Q1 FY 2027 pro forma revenue rose 20% year-on-year to INR 2,597 crore; EBITDA grew 30% to INR 576 crore, with margin expanding 170 bps to 22.2%.

• Mature units contributed 73% of revenue, growing 19% year-on-year; emerging units saw up to 95% revenue growth and 240% EBITDA growth.

• Net debt at combined level is INR 1,162 crore as of June 30, 2026.

• Normalised PAT (post NCI) for Aster grew 39% YoY to INR 125 crore in Q1 FY 2027.

• Exceptional items related to merger costs amounted to INR 114.38 crores (consolidated) and INR 109.79 crores (standalone), impacting net profit.

Outlook and guidance

• Targeting EBITDA margin of 24%-25% within two to three years post-merger, driven by synergy realization and operational leverage.

• Planned expansion to add over 4,170 beds, targeting a total of 15,077 beds by FY30, with 53% in existing and 47% in new facilities.

• Synergies expected to deliver 10%-15% incremental EBITDA, equivalent to INR 150-200 crore based on FY 2024 pro forma EBITDA.

• Medical Value Travel (MVT) business expected to grow over 50% annually, aiming for mid-single to double-digit revenue contribution in coming years.

• The company continues to invest in subsidiaries and associates, indicating ongoing expansion and strategic growth.